(Administrative Core) The multidisciplinary CCNE-TD program will be managed by the experienced team currently managing the Center for Cancer Nanotechnology Excellence and Translation (CCNE-T). Administrative core members include Drs. Sam Gambhir (PD/PI), Shan Wang (co-PI), Demir Akin (Deputy Director), and Billie Robles (Program Coordinator). Dr. Akin, who is the Deputy Director of our currently running CCNE and leads the Administrative Core, will continue in this role for the CCNE-TD. This dedicated and highly experienced administrative and management team is committed to ensuring that all components of the Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD) are successful and achieve all quantitative milestones. The Administrative Core team will also be provided additional resources that include an administrative assistant and a financial analyst (both from the Department of Radiology) to accomplish the following: 1. Monitor Research Projects to ensure that quantitative milestones are met. 2. Monitor Cores to ensure that state-of-the-art support services are available to the CCNE-TD. 3. Monitor progress of the entire program quantitative milestones. 4. Monitor budgetary needs and expenditures. 5. Ensure that all planned meetings, symposia, retreats, etc. are scheduled and conducted. 6. Maintain detailed minutes of all meetings for progress reporting. 7. Ensure timely and thorough progress reporting. 8. Ensure data sharing and dissemination. 9. Ensure communication flow among and between all groups and committees. 10. Monitor and expand education/interaction opportunities for CCNE-TD postdocs and graduate students. 11. Facilitate Center interactions as well as interactions outside of the Center. 12. Work closely with the NCI-assigned scientific officer, the NCI Alliance, and the caNanoLab.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA199075-01
Application #
8961577
Study Section
Special Emphasis Panel (ZCA1-TCRB-Q (M1))
Project Start
2015-09-04
Project End
2020-07-31
Budget Start
2015-09-04
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
$273,217
Indirect Cost
$89,172
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Bulte, Jeff W M; Daldrup-Link, Heike E (2018) Clinical Tracking of Cell Transfer and Cell Transplantation: Trials and Tribulations. Radiology 289:604-615
Lee, Jung-Rok; Appelmann, Iris; Miething, Cornelius et al. (2018) Longitudinal Multiplexed Measurement of Quantitative Proteomic Signatures in Mouse Lymphoma Models Using Magneto-Nanosensors. Theranostics 8:1389-1398
Sinclair, Robert; Liu, Yunzhi; Lee, Sangchul et al. (2018) Contributions to High Resolution and In Situ Electron Microscopy. Microsc Microanal 24:10-11
Tocchio, Alessandro; Durmus, Naside Gozde; Sridhar, Kaushik et al. (2018) Magnetically Guided Self-Assembly and Coding of 3D Living Architectures. Adv Mater 30:
Gambhir, Sanjiv Sam; Ge, T Jessie; Vermesh, Ophir et al. (2018) Toward achieving precision health. Sci Transl Med 10:
Abou-Elkacem, Lotfi; Wang, Huaijun; Chowdhury, Sayan M et al. (2018) Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24:1574-1585
Wang, Jeffrey B; Aryal, Muna; Zhong, Qian et al. (2018) Noninvasive Ultrasonic Drug Uncaging Maps Whole-Brain Functional Networks. Neuron 100:728-738.e7
Malhotra, Meenakshi; Sekar, Thillai Veerapazham; Ananta, Jeyarama S et al. (2018) Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. Oncotarget 9:21478-21494
Li, Jingchao; Rao, Jianghong; Pu, Kanyi (2018) Recent progress on semiconducting polymer nanoparticles for molecular imaging and cancer phototherapy. Biomaterials 155:217-235
Parizi, Kokab B; Akin, Demir; Wong, H-S Philip (2018) Internalization of subcellular-scale microfabricated chips by healthy and cancer cells. PLoS One 13:e0194712

Showing the most recent 10 out of 36 publications